60-year-old German man likely seventh person to be effectively cured from HIV
A 60-year-old German man is potentially the seventh person cured of HIV through a stem cell transplant. The procedure, not widely applicable, shows promise for HIV cure research without complete gene elimination.
Read original article
A 60-year-old German man is likely the seventh person to be effectively cured of HIV after receiving a stem cell transplant, as announced by doctors. This procedure, which is only suitable for individuals with both HIV and aggressive leukemia, is not widely applicable to the nearly 40 million people worldwide living with HIV. The patient, referred to as the "next Berlin patient," underwent a bone marrow transplant in 2015 and ceased taking anti-retroviral drugs in late 2018. Medical researchers report that almost six years later, he shows no signs of HIV or cancer. While not confirmed, the case is highly suggestive of an HIV cure, according to Christian Gaebler, a doctor-researcher involved in the treatment. This development is seen as promising for the search for an HIV cure that could benefit a larger pool of patients, as it demonstrates that complete elimination of the CCR5 gene may not be necessary for successful gene therapy.
Related
Scientists create a cell that precludes malignant growth
Scientists at the University of Helsinki developed a cell preventing malignant growth, enhancing therapies for diseases like diabetes. Engineered cells show promise in regulating glucose levels and evading immune rejection, advancing safer cell therapies.
HIV breakthrough: Trial shows drug provides 100% protection
A trial in South Africa and Uganda revealed lenacapavir, a new PrEP drug given twice yearly, provided 100% protection against HIV in young women, outperforming daily options. The promising results may offer a more manageable prevention approach.
New HIV Prevention Drug Shows 100% Efficacy in Clinical Trial
A new HIV prevention drug, lenacapavir, has shown 100% efficacy in a trial in South Africa and Uganda for young women. It outperformed daily pills like Truvada and Descovy, offering hope for improved prevention methods.
Immunotherapy Is Changing Cancer Treatment Forever
Immunotherapy, especially in glioblastoma cases, has shown significant progress. Mass General researchers use genetically modified white blood cells to target tumors, leading to rapid regression. This innovative approach offers hope for challenging cancer cases.
With seventh person seemingly cured of HIV, signs of hope for a broader cure
A seventh person, dubbed "The Next Berlin Patient," is cured of HIV after a bone marrow transplant from a donor with a rare genetic mutation. This breakthrough offers hope for a broader cure approach.
8 commentsEvery time I hear someone praise Reagan all I can think about is how sat on his hands and did nothing while a hundred thousand Americans died - 30,000 in the last year of his presidency alone - because of bigotry on the part of him and the Christian Right, who are still to this day screaming that LGBTQ people shouldn't have the same rights as everyone else.
Related
Scientists create a cell that precludes malignant growth
Scientists at the University of Helsinki developed a cell preventing malignant growth, enhancing therapies for diseases like diabetes. Engineered cells show promise in regulating glucose levels and evading immune rejection, advancing safer cell therapies.
HIV breakthrough: Trial shows drug provides 100% protection
A trial in South Africa and Uganda revealed lenacapavir, a new PrEP drug given twice yearly, provided 100% protection against HIV in young women, outperforming daily options. The promising results may offer a more manageable prevention approach.
New HIV Prevention Drug Shows 100% Efficacy in Clinical Trial
A new HIV prevention drug, lenacapavir, has shown 100% efficacy in a trial in South Africa and Uganda for young women. It outperformed daily pills like Truvada and Descovy, offering hope for improved prevention methods.
Immunotherapy Is Changing Cancer Treatment Forever
Immunotherapy, especially in glioblastoma cases, has shown significant progress. Mass General researchers use genetically modified white blood cells to target tumors, leading to rapid regression. This innovative approach offers hope for challenging cancer cases.
With seventh person seemingly cured of HIV, signs of hope for a broader cure
A seventh person, dubbed "The Next Berlin Patient," is cured of HIV after a bone marrow transplant from a donor with a rare genetic mutation. This breakthrough offers hope for a broader cure approach.